Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.

MLA

Toiyama, Yuji, et al. “Co-Expression of Hepatocyte Growth Factor and c-Met Predicts Peritoneal Dissemination Established by Autocrine Hepatocyte Growth Factor/c-Met Signaling in Gastric Cancer.” International Journal of Cancer, vol. 130, no. 12, June 2012, pp. 2912–21. EBSCOhost, https://doi.org/10.1002/ijc.26330.

APA

Toiyama, Y., Yasuda, H., Saigusa, S., Matushita, K., Fujikawa, H., Tanaka, K., Mohri, Y., Inoue, Y., Goel, A., & Kusunoki, M. (2012). Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. International Journal of Cancer, 130(12), 2912–2921. https://doi.org/10.1002/ijc.26330

Chicago

Toiyama, Yuji, Hiromi Yasuda, Susumu Saigusa, Kouhei Matushita, Hiroyuki Fujikawa, Koji Tanaka, Yasuhiko Mohri, Yasuhiro Inoue, Ajay Goel, and Masato Kusunoki. 2012. “Co-Expression of Hepatocyte Growth Factor and c-Met Predicts Peritoneal Dissemination Established by Autocrine Hepatocyte Growth Factor/c-Met Signaling in Gastric Cancer.” International Journal of Cancer 130 (12): 2912–21. doi:10.1002/ijc.26330.